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J. LINDSEY CHALK.   Laboratory animal allergy:
industrial hygiene groundwork for a prospective
epidemiologic study.   (Under the direction of
DR. JOHN M. DEMENT)
This paper discusses some basic principles of allergy and asthma,
and provides an overview of laboratory animal allergy and aeroallergen
quantitation methods. Laboratory animal worker exposures to total and
respirable particulate concentrations were determined from personal
samples (both time-weighted average and task specific) and area
samples. All results were below threshold limit values for nuisance
dust (10 mg/M^-total, 5 mg/M-^-respirable) and hardwood dust (1 mg/M^).
The highest particulate exposures existed in the area on the clean side
of the automatic cage washers (0.97 mg/M^-total, 0.05 mg/M^-respirable,
TWAs) where hardwood bedding chips were dispensed into clean cages.
The respirable percent of the samples varied widely (5 to 100%). The
air samples collected will be analyzed by RAST inhibition for rat uri¬
nary protein and rat dander, and will be used for dose determination in
a prospective study on the development of laboratory animal allergy and
asthma. A system of dose calculation and data presentation is suggest¬
ed for the follow-up epidemiology.
INTRODUCTION
The Status of Aeroallergen Sampling in LAA
This study was intended to address some of the questions raised by
current LAA (laboratory animal allergy) related research. Personal air
sampling has not been used to quantitate an individual's breathing zone
exposure to allergenic material, nor have specific tasks involved with
animal work been evaluated for their exposure potential. Concentra¬
tions of specific airborne allergens in laboratory animal holding rooms
have been measured, but actual personal inhalation exposure is still a
matter of conjecture. In order for critera for a recommended standard
to be developed, exposures need to be linked to effects (or dose to
response). Only within the past few years has it been possible to
measure aeroallergen dose meaningfully. Now that dose can be corre¬
lated to a response, criteria for development of a standard will be a
matter of examining the evidence to discover the cogent picture.
The NIEHS Project
The dose-response correlation will be accomplished by a NIEHS
(National Institute of Environmental Health Sciences)
clinical/epidemiologic survey which incorporates the quantitative
results begun by this study and relates exposure to response data elu¬
cidated by skin prick tests, RAST inhibition tests, and questionnaires.
Exposures are most meaningful if expressed as 8-hour time-weighted
averages, and in addition to identifying average task-specific peak
exposures (e.g., cage washing, necropsy, lavage, etc.), these para¬
meters identify the higher risk jobs and tasks, thereby enhancing
accurate, quick recognition, evaluation and control of hazards. Also
the relationship of gravimetric results with RAST inhibition results
for specific antigens should be evaluated. A positive correlation may
be significant, since gravimetric sampling and measuring techniques are
much simpler than the latter, but may be useful as an index of allergen
activity. Particulate concentration may also profoundly effect
the allergen activity in some hitherto unrecognized way.
Objectives
The objectives of the present study were to: 1) determine per¬
sonal exposures to total and respirable dusts in laboratory animal
handling areas, 2) establish a hierarchy of tasks/jobs by hazard, or
dose intensity, for use in future industrial hygiene and epidemiologic
studies, 3) investigate the total particulate / respirable particulate
relationship of LAA-inducing aerosol, 4) identify interim control stra¬
tegies in view of the current data, and 5) provide preliminary exposure
data to be used in a concomitant clinical/epidemiologic study.
LITERATURE REVIEW
Theory and Mechanisms of Allergy and Asthma
Allergies and asthma are among the most common of all health
problems experienced in this country. It has been estimated that about
one out of e^ery  six Americans suffers from at least one allergic
problem. (48) The direct and indirect costs to these afflicted persons
exceeds $1.8 billion. The cost to Americans and to American industry
and business for approximately 35 million annual sick days and more
than 90.5 million days of restricted activity each year is incalcu¬
lable. (48) Despite explosive advances in recent years of our
understanding, diagnosis, and treatment of asthma and allergic
diseases, additional research is needed before the debilitating effects
of these disorders are brought under control.
Allergy may be defined as unfavorable physiologic events mediated
by a variety of different immunologic reactions. Allergic reactions
can involve any organ system in the body. Allergy is a harmful hyper¬
sensitivity to a specific substance; it is the antithesis of immunity.
The concept of immunity centers on the body's ability to recognize
foreign, "nonself" material, such as microorganisms, pollen, and dust,
and react in such a way as to control or destroy the invading material.
However, when the same ordinarily protective system produces a harmful
reaction we refer to this as an allergic response.
An "antigen" is any substance which elicits a reaction from the
immune system. The immune system recognizes structures on the antigen
as being nonself and reacts against them. The reaction may be mediated
by the action of cells (cell-mediated immunity) or by proteins in the
blood called antibodies (humoral immunity).
Discoveries in the early 1960's led to a hypothesis that is
currently one of the central dogmas of immunology today. This hypothe¬
sis states that there are two distinct types of immunocompetent white
blood cells: one which requires the thymus, a lymph gland in the
chest, for development and is responsible for cell-mediated immunity
(T-lymphocytes); and the other, developing independent from the thymus,
is responsible for the mediation of the antibody responses
(B-lymphocytes). (18) Phagocytes, a third type of white blood cell,
participate in the immune response. They are scavengers and include
macrophages, neutrophils, and eosinophils. T cells, B cells, and pha¬
gocytes all originate in the bone marrow.
T cells can directly attack an antigen, and produce chemical
"mediators" that attract or activate other parts of the immmune system.
Cell-mediated immunity is a major factor in the rejection of
transplanted organs, tissue grafts, and may be important in cancer pro¬
tection. B cells interact with T cells; they divide and change into
cells that can produce large numbers of specific "antibodies" when they
react with an antigen and may be assisted in this by T cells. The
antibodies produced are specific to the B cell that produced them.
This illustrates why vaccination works by injecting dead or weakened
antigens which prime the immmune system for a rapid response to a real
attack.
Antibodies are the mediators of humoral immunity. They are
defined as proteins that are formed by the host in response to an anti-
**- "iB»KW»-^.!WT«>*J»S»-lJ'"*HS?W-
gen and react specifically with that antigen. The special group of
five classes of proteins comprising the antibodies are called the
"immunoglobulins": IgG, IgA, IgM, IgD, and IgE. IgG is the most abun¬
dant immunoglobulin and includes the primary serum antibodies against
bacteria, viruses, and exogenous toxins. IgG antibodies are at times
involved with certain phagocytes to facilitate phagocytosis. IgG is
the only class of antibodies that crosses the human placenta to become
the principle antibody of the newborn. IgA antibodies, found mainly in
body secretions such as saliva, tears, and nasal secretions, serve as a
first line of defense against inhaled or ingested microorganisms.
IgD's function is not well understood. IgM is large and binds most
efficiently to antigens and to "Cl". CI is the first component of the
"complement system", a group of blood enzymes that play a vital role in
immunity and will be discussed shortly. IgG can also activate the
complement system. IgE (reagenic) antibodies were discovered in 1921
by Prausnitz and Kustner when they determined that serum could transfer
cutaneous sensitivity, but were not isolated until 1966. Most IgE is
on the surface of basophils and mast cells, not free in blood serum
(see Figure 1). Antigens that bind to IgE on these cells are called
"allergens". Examples include airborne pollens, fungi, and animal
dander. Thus, most of the allergic reactions that plague many people
are due to IgE.
The lysosomes of tissue mast cells and circulating basophils con¬
tain most of the histamine in the human body. Histamine, which regu¬
lates the permeability of capillaries, is released with other mediators
when antigens bind to the IgE on basophils and mast cells. This is the
beginning of the allergic reaction. The released mediators then begin
their harmful work: fluid leaks into extravascular spaces, smooth
Figure 1. NORMAL IMMUNOGLOBULIN LEVELS







muscle has spasms, phagocytic cells are attracted, and platelets are
activated.
The complement system may enhance the effects of antibodies or may
directly interact with microbes. It is the primary humoral response to
the binding of antigen and antibody, and one of the principal causes of
inflammation induced by the immune system (20). The main functions of
the complement system in killing bacteria are 1) the attraction of pha¬
gocytes, 2) the increased adherence of phagocytes to antigens, and 3)
cell lysis. Late in the nineteenth century Bordet first described the
complement system. This series of proteins has come to be known as the
"classic" pathway, since in 1954 an alternate, but related pathway was
described by Pillemer and his colleagues. The alternate pathway is
triggered in the absence of antibodies but the results are the same:
an amplification loop, inflammation and host defense effects, and ulti¬
mate destruction of the invasive material.
Earlier it was pointed out that the immune pathways that function
as the protective mechanisms can also cause injury. The most widely
used classification of the hypersensitivity, or allergic, reaction has
four groups. Type I is applicable to LAA, and will be discussed last.
Type II, cytotoxic hypersensitivity, occurs when circulating antibodies
develop against a cell membrane or an antigen associated with a cell
membrane. Autoimmune hemolytic anemia and drug-induced hemolytic ane¬
mia are examples, where antibodies to red cells or antibodies to a drug
bound to a red cell may be found. A transfusion with an incompatible
blood type will also incite a Type II reaction. The complement system
is often involved with the cytotoxic reaction, usually activated by IgG
or IgM.
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Type III, immune complex hypersensitivity, occurs from hours to
several days after exposure to antigen. In this case, antibodies com¬
bine with soluble antigens in blood, forming immune complexes. The
immune complexes pass into extravascular spaces, and deposit in the
walls of blood vessels or kidneys. The complement system is also
involved in producing the disease state. An example of this type of
reaction is serum sickness-- a reaction to an injection of an animal
serum.
Type IV, delayed hypersensitivity, is cell-mediated, whereas Types
I, II, and III are humoral responses. This type of reaction reaches
its peak about two days after exposure. Here T cells react directly
with the antigen, initiating a complex process of cell production and
release of lymphokines which bring more cells into the reaction to
attack the invader. Examples of the Type IV reaction can be found in
tuberculin immunity, graft rejection, and contact dermatitis, such as
poison ivy.
Type I, immediate hypersensitivity, goes by many names
(anaphylactic or reagin-dependent hypersensitivity, etc.) and is the
immmune response that is synonymous with allergy. Within seconds or
minutes of exposure to antigen, this mechanism produces its effect;
examples of Type I reactions include hay fever, some asthma and hives,
some food and drug reactions, insect-sting reactions, and anaphylactic
shock (a severe, potentially fatal reaction). The bridging of two
adjacent IgE antibodies on the surface of a mast cell or basophil
triggers a series of intracellular events resulting in the release of
numerous preformed inflammatory mediators, such as histamine, and the
synthesis of new mediators, such as slow-reacting substances (the
wi^^^^^'ia^-'''^f?^^f^^«^'
leukotrienes), platelet activating factor, and prostaglandins. These
substances cause edema, spasm of smooth muscle, granulocyte attraction,
activation of platelets, and increased production of mucous.
The first necessary step in developing an allergy is exposure to
the antigen, which may be a pollen, dust, a mold, animal dander, animal
urinary protein, or some other substance. IgE antibodies specific to
the antigen are formed, usually having a molecular weight of about
190,.000; IgE is a monomer of two short and two long polypeptide
chains-- the basic building block of all immunoglobulins. The prin¬
ciple site of IgE synthesis is the lymphatic tissue of the respiratory
and gastrointestinal systems, but especially the tonsils and adenoids.
IgE is found in a lower concentration in the blood than any other immu¬
noglobulin class. Evidently IgE synthesis by B cells is under careful
and constant regulation by both helper and suppressor T cells with
suppression usually predominating. It is thought by some that allergic
diseases represent a "breakthrough" phenomenon in which the suppressive
mechanisms that normally keep IgE levels low are abrogated (4).
Up to 500,000 IgE antibodies can attach to a mast cell or
basophil. In humans mast cells far outnumber basophils; mast cells are
found primarily in tissues such as the skin, the respiratory tract, and
the gastrointestinal tract, while basophils are found in the blood.
When the allergic subject encounters the specific antigen again, it
binds only to the specific antibodies now sitting on the surfaces of
cells, bridging them. This signals the cell to release its granules of
chemical mediators, which leads to symptoms such as wheezing, sneezing,
runny eyes, itching, abdominal pain, wretching, or diarrhea. The
mediators lead to tissue injury either by direct effect on blood
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vessels, nerve fibers, smooth muscles in the lungs, or by attracting
other damage-producing cells to the site. Mediators released from
human mast cells and basophils include: 1) histamine--causes itching,
constriction of bronchial tube smooth muscle, and increase of blood
vessel permeability, 2) slow-reacting substance of anaphylaxis
(SRS-A)-- the most powerful constrictor of human bronchial tube smooth
muscle known, 3) eosinophil chemotactic factor of anaphylaxis (ECF-A)--
attracts eosinophils, 4) platelet activating factor (PAF)-- stimulates
the release of secondary mediators from platelets and causes platelet
aggregation (33), 5) neutrophil chemotactic factor (NCF)--attracts
neutrophils, 6) superoxide (Op")-- possibly deteriorates the mucous
membrane, as in severe asthma, 7) bradykinin-- a potent blood-vessel
dilator, 8) prostaglandins— tissue reactions such as bronchodilation
and bronchoconstriction. Some mediators are preformed while others are
newly synthesized following basophil or mast cell membrane activation.
Of the preformed mediators, some are eluted rapidly from granules,
others slowly; of the newly formed mediators, some are formed within
the mast cell or basophil, others are generated secondarily by other
cells or from extracellular fluid. Mediators are still being investi¬
gated and defined. It is important to recognize that these harmful
cells and chemicals are intended for protecting the body, and do, in a
normal immune response.
The allergic response may be complicated by ear inflammation or
sinusitis, but the most common allergic condition is allergic rhinitis,
inflammation of the nasal mucous membranes. Although never fatal, rhi¬
nitis significantly impairs normal function of the sufferer, often
causing absences from work and school. Type I allergic response can
^T!^',Wiiwq!^^ipp.«i4tiL ijpii - ͣ ͣ": ͣ- ͣi»»,'«IR?"
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range from mild effects to life-threatening; other Type I disorders
include bronchial asthma, anaphylaxis, and urticaria.
The skin prick test is the most common diagnostic procedure used
to demonstrate immediate hypersensitivity. A drop of antigen con¬
centrate is placed on the skin, then the skin is pricked with a needle.
The degree of sensitivity is correlated by the wheal-and-flare response
after 15 minutes. If the skin prick test is negative, intradermal
injection of antigen may be used to demonstrate sensitivity. Although
not a precise indicator of allergic conditions, the radioimmunosorbent
test (RIST) may be used to measure total IgE. The radioallergosorbent
test (RAST), which measures antigen-specific IgE, is more helpful.
Both methods can measure IgE levels to 1 ng/ml. The RAST test will be
discussed in more depth later.
Allergies are controlled by a combination of genetic and nongene-
tic factors. One may inherit a tendency to be allergic, and usually
someone suffering from an allergic disease has a close relative who
also has some allergic disease.
Advances in drug therapy have resulted in much relief for allergy
and asthma sufferers. However, side effects and erratic responses to
the drugs do occur, since, as many drugs, they are mostly developed
through experiment and observation of their effect on symptoms, rather
than with a detailed knowledge of the molecular activity taking place
in vivo. Immunosuppression-- the suppression of the immune system by
drugs or irradiation-- is also under investigation. Immunotherapy, or
desensitization, often referred to as "allergy shots", is also an
effective treatment. This technique is one of gradually increasing the
amount of injected allergen which is known to trigger the allergic
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response of the patient. Originally this was thought to reduce or eli¬
minate IgE, but it has been determined that IgG is proliferated and
blocks the antigen from reacting with IgE, thus avoiding an allergic
reaction.
Although difficult to define, asthma is a special aspect of
allergic reaction that warrants some discussion. Asthma is a condition
characterized by widespread narrowing of the bronchial airways, which
changes in severity over short periods of time either spontaneously or
under treatment, and is not due to cardiovascular disease. During an
attack, the asthmatic suffers shortness of breath and wheezing.
Bronchodilator drugs offer relief in most cases. There are many and
varied causes of asthma. Allergy can be a sufficient but not an exclu¬
sive cause of asthma. Some causes involve an allergic reaction
(extrinsic asthma) and for others no outside factor such as an allergen
can be determined (intrinsic asthma). Millions of Americans suffer
from asthma. Asthma and allergic diseases are the leading chronic
disorders in children under 17. If asthma attacks are seasonal and
appear to be related to allergy, skin tests are often employed to help
determine the causal allergen and to help in treatment planning.
Airway obstruction can be present even when the asthmatic has no
symptoms. During an asthmatic attack, the smooth muscle of the
bronchioles constrict and narrow the airway. The bronchiole linings
themselves become swollen and filled with eosinophils. Excess mucous
is produced, further plugging the airways. Breathing becomes forced,
and the rush of air through narrowed airways and the vibration of
mucous there produces wheezing sounds. Though the anatomical changes
are well described, the underlying mechanism is still not well
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understood. It appears that all the layers of the airway wall have
physical alterations. The size of the bronchial smooth muscles of
asthmatics is increased, possibly due to prolonged constriction or
simply to increased susceptibility to contraction. Allergen-induced
asthma usually causes an immediate decrease in lung function, which may
be followed by a secondary phase of bronchoconstriction developing 4 to
6 hours later. Rarely does the late reaction develop without the imme¬
diate reaction.
In an acute asthma attack, the trapped air due to narrowed airway
passages causes uneven ventilation and perfusion which leads to
decreased arterial blood oxygen (hypoxemia). Hyperventilation first
decreases carbon dioxide in the blood then the CO2 level increases as
obstruction worsens. Severe asthma attacks can be life-threatening.
Also, the overinflation of the lungs and the increased pressures
required for inhalation in an asthma attack put considerable stress on
the cardiovascular system.
Histamine plays a role in asthma, but antihistamines, which are so
helpful in controlling hay fever, are usually ineffective in treating
asthma. However, immunotherapy and drug therapy are used widely with
considerable success. Subjects sensitive to a specific allergen will
find their symptoms greatly reduced with removal of the antigen, but
controlling the environment is often difficult. So it is with allergic
and asthmatic subjects whose symptoms are triggered by laboratory ani¬
mals.
Laboratory Animal Allergy
With a working knowledge of the theory and mechanisms of allergy
and asthma attention may now be focused on the problem of laboratory
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animal allergy (LAA). LAA may be described as an allergic disorder
characterized by conjunctivitis, rhinitis, urticaria, or asthma, or a
combination of these symptoms, and is causally related to exposure to
allergens derived from laboratory animals. The syndrome has the typi¬
cal characteristics of an IgE mediated condition, but can trigger a
type III (arthus-type) asthma attack hours after exposure. Although
the list of animals used by scientific and medical workers is endless,
five species comprise 99% of laboratory animals in use today: rats,
mice, guinea pigs, rabbits, and hamsters. Personnel in contact with
laboratory animals are a diverse occupational group with a wide range
of socioeconomic and educational background. Included are veteri¬
narians, physicians, dentists, senior scientists, animal research tech¬
nicians, laboratory technicians, geneticists, breeders, and animal
caretakers. A typical employee having acquired LAA has been described
as a person of either sex, a scientific or technical worker with
laboratory animals, 23 to 32 years of age, with a family history of
atopy, one who has developed LAA within three years of the start of
close contact with laboratory animals, exhibits an immediate hypersen¬
sitivity (Type I) reaction in less than 10 minutes, has at least 3 cli¬
nical symptoms, such as rhinitis, asthma, and cough, and may be
allergic to more than one species (25).
Although allergy acquired from laboratory animals has been docu¬
mented for over a century, it has only recently come to be considered a
significant occupational disease. In Great Britain animal asthma is
now a prescribed industrial disease under national industrial injuries
laws, entitling the affected worker to compensation from central
government funds (8,10,26). It has been estimated that 35,000 workers
15
and scientists in the United States are regularly exposed to laboratory
animals, and that there are 4,700-8,600 cases of LAA and 2,400-3,700
laboratory animal asthmatics in the UK alone (13). Many of these
employees changed jobs or specific animal contact. Many others resigned
employment. There is apparently no uniform policy regarding the
problem of allergy to laboratory animals in US animal facilities.
While 103 of 155 surveyed animal research facilities required a
preemployment medical examination, only six of these included hypersen¬
sitivity screening (26). The attention to and knowledge of LAA has,
nevertheless, been growing steadily. Examples in the literature
include an LAA case discussed by Sorrell and Gottesman in 1957 (41), 10
cases in Sweden discussed by Rajka in 1961 (35), and a review of the
LAA problem by Patterson in 1964 (34). This attention to LAA and new
knowledge pertaining to it has virtually exploded in the last ten
years, due in part to the advancement of the radioallergosorbent test
(RAST), which will be discussed. Despite the mounting numbers of ani¬
mal allergy case histories reported in the literature (17) and the
knowledge explosion, allergy texts have barely begun to lend more than
a perfunctory comment on the topic (32,28).
Numerous studies of the prevalence of LAA have emerged (6,38,21,
24,8,25,31,12), and with them many of the patterns of LAA are becoming
defined. It appears that 15-30% of exposed workers suffer from LAA.
However it is likely that the problem is greater than it appears, since
job migration and active avoidance of animal exposure jobs doubtless
occur. The study performed by Davies and McArdle found that nearly
half of those who worked with laboratory animals and developed symptoms
had to stop work permanently or temporarily. The frequencies of
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hayfever, eczema, and bronchitis were not elevated among exposed
workers, but asthma, nasal symptoms and eye symptoms were elevated
(13). Urine has been found to be an important source of allergens
(30,46), and does not appear to be strain specific (27). Atopy, or
predisposition (by familial or personal history of asthma or allergy),
skin testing, and RAST scores all seem quite dissociated from the deve¬
lopment of post-employment allergy, but closely associated with the
development of asthma due to LAA (13,31,12). The practical value of
pre-employment hypersensitivity screening, therefore, appears to be
somewhat limited.
Slovak and Hill proposed that LAA occurs in two distinct forms:
regional LAA syndrome and progressive LAA syndrome (38). In this
model, regional LAA is characterized by rhinitis with negative skin
prick tests, and progressive LAA consists of rhinitis leading
progressively to asthma with positive prick tests. Atopes appear not
to be at special risk of developing LAA but if they do it is more
likely to progress to asthma. Slovak and Hill suggest the need for a
prospective study of LAA to establish the incidence and prevalence of
LAA. They state, "Such a study could be definitive, especially if it
were designed to run alongside a properly constituted occupational
hygiene survey, so that some quantitative correlation could be made
with incidence and prevalence. Only then would it be possible to offer
an opinion on the establishment of hygiene standards...." Such pro¬
spective studies will allow specific recommendations to be made about
the protective efficacy of specific designs for cages, animal rooms,
experimental rooms, ventilation systems, and other protective equip¬
ment.
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Quantitation of Antigen Exposures
Since the problem of LAA cannot be contained in a purely clinical
or medical arena, contributions are required from the field of
industrial hygiene. A brief overview of the history of aerobiologic
measurement techniques follows.
Early investigations of pollen in the nineteenth century empha¬
sized an approach utilizing the principle of gravitational settling of
particles upon adhesive-coated slides. Such methods were severely
limited for deriving quantitative results since the tendency of a par¬
ticle to cross airflow streamlines is almost exclusively a function of
its size (40). Nevertheless, traditional reliance on gravitational
collection was reinforced in 1946 when a covered slide support proposed
by Durham (14) was adopted as a standard pollen sampler. Such samplers
owe their usefulness to low cost, durability, and power source indepen¬
dence. Though attempts have been made to derive air volume by this
method, particles enumerated on gravity slides or open culture plates
represent an unknown and incalculable volume of air.
Impaction type samplers have also been used, in which the collec¬
tion surface acts upon the air mass, rather than vice versa. This
group of devices includes the Rotorod sampler, which has two upright
arms rotating at about 2,500 rpm on a small motor. The arms are coated
with adhesive and microscopically examined after collection. They are
most useful for collection of particles larger than 5-10 urn. These
samplers are less susceptible to anisokinetic sampling error than suc¬
tion type impactors.
Suction type impactors force impaction of small particles by draw¬
ing air through specially designed flow channels which cause the air to
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undergo rapid directional changes. Examples of such instruments
include the Andersen sieve impingers, cascade impactors, and the Hirst
automatic spore trap.
Filter samplers, especially Hi-Vol fiber filter sampling, is often
used as well. Though high volume and a large filter are advantageous,
microscopic inspection is difficult. Membrane filters lend themselves
better to morphological examination.
As industrial hygienists have participated more in the occupation¬
al health and clinical work support, a broader range of devices has
been put to use, including electrostatic collectors, thermal precipita¬
tors, and elutriators (7). Personal samplers using porous membrane
filters and/or size selective cyclones have gained wider usage, and are
the choice of this study. These samplers provide a truer picture of
actual human inhalation exposure.
Laboratory animal derived aeroallergens present a broad particle
size distribution and diverse morphology. This picture is supplemented
by a nondescript, complex mixture of wood chip bedding, animal feed,
dust, and microorganisms. Gravimetric and RAST (described below) are
the most effective means of quantifying animal-derived allergens, since
the allergens are not viable and bioamplification is therefore not
possible, and since microscopic inspection is tedious, difficult, and
only vaguely quantitative.
In the 1960's a remarkable serological assay was introduced for in
vitro measurement of IgE antibodies: the RAST (radioallergosorbent
test). RAST greatly facilitated fundamental research in allergy, but
launched a growing controversy as a replacement for the time-honored
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Prausnitz-Kustner (P-K) skin test (29,2,1,5). Work continues as
investigators refine and perfect the RAST and its applications to LAA.
A vast amount of new immunologic information on animal allergens has
been generated in the last ten years. RAST tests using urinary pro¬
teins from mice, rats, guinea pigs, and rabbits have been developed and
used in the diagnosis of LAA (15). A variation on the RAST, called the
"mini-RAST", was developed which in some cases allows the use of much
less allergen without compromising sensitivity (19).
But what 2^ the RAST, and how does it work? The test for antibody
content of a serum must first be understood. The serum antibody con¬
tent can be assessed by its ability to bind to antigen which has been
insolubilized either by coupling to an immunoadsorbent or by physical
adsorption to a plastic tube; the bound immunoglobulin may then be
estimated by addition of a radiolabelled anti-Ig raised in another spe¬
cies. That is, a patient's serum is added to a plastic tube coated
with antigen; the antibodies will bind to the antigen and remaining
serum proteins can be readily washed away. Bound antibody can now be
estimated by addition of radiolabelled purified anti-human Ig; after
rinsing out excess unbound reagent, the radioactivity of the tube will
be a measure of the antibody content of the patient's serum. The
distribution of antibody in different Ig classes can be determined by
using specific antisera. In the RAST test for IgE antibodies in
allergic patients, the allergen (e.g., rat urinary protein extract) is
covalently coupled to a paper disc which is then treated with patient's
serum. The amount of specific IgE bound to the paper is then estimated
by addition of labelled anti-IgE (Figure 2).
But how is antigen measured? This is done by a slightly different











FIGURE 2. The RAST Test for Quantitative Determination of Antibody IgE.  (Adapted from Roitt, 1980.)
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Figure 3. Principle of radioimmunoassay (simplified by assuming a \/ery




Free Ag    Bound Ag radioactivity
A) 15 *Ag + 10 Ab
B) 15 *Ag
15    Ag + 10 Ab
















Ag = radioactive antigen
Ag = unlabelled antigen
Ab = antibody
A) If we add 15 mol of radiolabelled Ag to 10 mol of Ab, 5 mol of
Ag will be free and 10 bound to Ab. The ratio of the counts of
free to bound will be 1:2.
B) If we now add 15 mol of unlabelled Ag plus 15 mol radio Ag to
the Ab, again only 10 mol of total Ag will be bound, but since
the Ab cannot distinguish labelled from unlabelled Ag, half will
be radioactive. The remaining antigen will be free and the
ratio free:bound radioactivity changes to 2:1. This ratio will
vary with the amount of unlabelled Ag added and this enables a
calibration curve to be constructed.
Reference: Roitt, 1980
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antigen to a limited fixed amount of antibody can be partially inhi¬
bited by addition of unlabelled antigen and the extent of this inhibi¬
tion can be used as a measure of the unlabelled material added (Figure
3) (36). Methods vary in the means used to separate free antigen from
that bound to antibody.
With the development of methods for labelling antigens to a high
specific activity, very low concentrations down to the 10-12 g/ml level
can be detected. A disadvantage for some applications is that these
methods cannot distinguish active protein molecules from biologically
inactive fragments which still retain antigenic determinants.
Nevertheless, RAST has been a great aid to immunology, and more speci¬
fically, to the investigation of LAA.
The first attempts to quantify animal allergens in the workplace
were made at Oak Ridge National Laboratory in Tennessee in 1974 (24).
Three techniques were used for mouse-derived allergens: morphologic
identification in air samples collected on Millipore filters, quan¬
tification of dust and extractable protein nitrogen determined by the
micro-Kjeldahl technique in dust collected in the same way, and double
diffusion in agar gel using rabbit antisera to mouse serum, dander, and
urine. The results of the first two methods showed a positive correla¬
tion with the size of the animal population in the area, but the tech¬
niques were not specific with regard to allergen. The last technique
was mainly qualitative, but did seem to indicate strong allergenicity
of urine as compared to serum and the low allergenicity of food and
bedding. The study also illuminated the allergenic importance of
soluble material on dander.
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Then in 1979 a RAST inhibition technique was used to demonstrate
mouse allergen in the dust from a mouse-inhabited room (37), though,
again, airborne allergen concentrations were not quantified.
Finally, in 1981 researchers at the Allergic Diseases Research
Laboratory of the Mayo Clinic in Rochester, Minnesota, adapted the RAST
inhibition technique to measure airborne allergens (3). This involved
collection of ragweed pollen or Alternaria fungal spores on the filter
sheet of a Hi-Vol air sampler. Particles greater than 0.3 urn diameter
were captured and eluted, then dialyzed and lyophilized. The eluates
were reconstituted and assayed for specific allergen activity by a RAST
inhibition assay. Their results showed a positive correlation with
pollen and spore counts by traditional morphologic identification.
About a year later the same laboratory published the results of
applying the technique to the laboratory animal allergy problem (45).
Airborne mouse pelt and urine allergen concentrations were investigated
in a mouse-care room and immunology laboratory and were found to range
from 1.8 to 825 ng/M^, varying with the number of animals in the room
and the degree of work activity. This was accomplished using a high-
volume air sampler to collect the air samples on fiber filter sheets.
In a recent study on three guinea-pig-derived allergens (42),
urine, pelt, and albumin, the first two were found to be cross-reactive
while the albumin allergen was not. Hi-Vol air samples were collected
in the animal housing room, a research laboratory, a library, and out¬
side. Guinea pig urine allergen activity was detected in all indoor
samples by RAST inhibition, pelt allergen activity was detected in the
former two indoor samples, and no guinea pig albumin was detected in
the air samples. Sizing of airborne particles with an Andersen cascade
iM^Wiut'l-
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impactor demonstrated that most of the allergen activity was associated
with particles of a diameter greater than 5 um and less than 0.8 urn.
The study implicated urine as being the major source of guinea pig
allergens, and showed that it is present in airborne particles small
enough to penetrate the lower respiratory tract when inhaled.
Another important recent study extending the knowledge of labora¬
tory animal-derived aeroallergens in the work environment was published
in 1983 by a group of researchers in the UK (16). That study employed
air samplers drawing air at 2 Lpm for 5 hours in four different rooms,
each room devoted primarily to a different species of animal, then RAST
inhibition assay of the samples. Their methods appeared reliable, and
so were extended to the evaluation of the effects of air change rates
and humidity on airborne allergen levels in the rat room. Their find¬
ings, in general, demonstrated that reducing the air changes increased
allergen levels, while increasing the humidity from 54% to 77% caused a
significant reduction in allergen levels.
In an unpublished paper presented at the Inhaled Particles Confer¬
ence in September 1985, M. Corn, et al, reported the results of an air
sampling study for rat derived allergens (11). This study evaluated
particle size distributions in an animal facility, as well as total
particulate. Urinary and salivary antigen was quantified by indirect
ELISA (enzyme-linked immunosorbent assay), rather than RAST inhibition.
Personal samples yielded airborne antigen concentrations about one
order of magnitude higher than corresponding area samples, but since
the extraction efficiencies of the antigenic proteins were unknown, the
results were lower limit estimates of concentrations. Other
interesting observations from the study were that 1) antigen to par-
25
ticulate weight-to-weight ratio appeared to be approximately 1/1,000
(possibly the lowest known mass ratio of active chemical/contaminant
airborne particulate to carrier), 2) changes in antigen concentration
levels and total particulate levels did not coincide, and 3) approxi¬
mately 70% of the antigen by weight was associated with respirable par¬
ticles. Their study did not isolate samples by specific tasks.
Recent literature has shown more industrial hygiene involvement in
the problem of LAA: the potential value of a powered, air-purifying
helmet type respirator to protect laboratory animal workers has been
examined (39), and the first attempt has recently been made at a viable
volumetric air sampler designed specifically for immunochemical
aeroallergen quantitation (43).
METHODS
Description of Facilities Studied
The south campus facility of NIEHS at Research Triangle Park was
the site of all air sampling except the lavage samples, which were
collected at the north campus. The building consists of five modules,
most of which consist of five stories including the basement, with
interstitial space between all floors. Several completely separate
ventilation systems provide all laboratories, surgical suites, and ani¬
mal areas with about 15 air changes per hour of single-pass filtered
air. The animal areas and the surgical suite rooms are in the basement
of C and D Modules (see Figure 4) and are on ventilation systems
separate from any laboratory or office areas. Animal breeding and
holding room air is also preceded by a HEPA filter for the protection
of the animals. Air diffusers are centrally located in the ceiling of
animal rooms and most laboratories, while exhaust vents are located low
on the walls. Animal area air is strictly regulated at 72 plus or
minus 2 °C, and 50% plus or minus 5%  RH.
Holding and breeding rooms each have two doors. One opens from a
regulated clean corridor under positive pressure with respect to the
room, where clean cages, equipment, and food for animal husbandry is
obtained; the other door opens to a "dirty", or "return" corridor, un¬
der negative pressure with respect to the room, where soiled cages and
trash are left for subsequent removal. The contents of soiled cages
are dumped in hoppers in the cage wash area and loaded in the cage
f\
LP
-   i
^:   1 1        .   i
























3 High Access Animal   Holding   Rooms
4 Limited Access Animal Holding Rooms
5 Quarantine Animal Holding Rooms
28
washing machines. The clean cages emerge in the higher pressure clean
side, are filled with bedding, and the cycle is repeated. Water
bottles, racks, filter bonnets, and other equipment are circulated in
the same fashion.
Large narrow racks on wheels line the walls and form rows in ani¬
mal breeding and holding rooms. The racks have six shelves, but the
top shelf is rarely used. Approximately 25 clear plastic cages are
stored per rack, each with a HEPA filter bonnet, or cap. Food and
water is available to the animals from a holder which fits between the
cage and the filter. The rat population in a given holding room is
usually about 200-250 animals, having 3 to 5 rats per cage. Breeding
rooms generally have a much larger population. Bedding is changed
e^ery  3 or 4 days, along with food and water. Other species are bred
or stored in the same facility, usually in rooms dedicated to one spe¬
cies.
Most experimentation with animals occurs in the surgical suite
rooms, which are in the basement of the same modules. When animals are
taken to other parts of the facility (i.e., user laboratories) they are
not returned.
The bedding used is a carefully regulated mixture of beech, maple,
and birch wood chips. From 85 to 90% by weight of the bedding par¬
ticles are required to remain between the sieve sizes of 0.03 and 0.09
inches after a 5-minute shake. Both animal feed and bedding are
autoclaved and pneumatically delivered from a warehouse to the clean
side of the washroom for dispensing. The applicable TLV for airborne
particulate in the clean side of the washroom is 1 mg/M^ for hardwood
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dust, while the TLV for nuisance dust (10 mg/M^ total, 5 mg/M^
respirable) would apply to all other areas.
Air Sampling/Analysis Methods
Due to the extremely low levels of particulate found in many areas
where air samples were to be collected, a filter medium was needed
which would provide gravimetric stability. Preliminary tests showed
that accurate measurements were needed for as low as a 10 ug weight
change or better. Glass fiber filters and mixed cellulose ester
filters appeared to provide an accuracy of only plus or minus 100 ug at
best, while polyvinyl chloride (PVC) filters provided an accuracy of up
to plus or minus 1 ug. An extremely small pore size was desired, since
antigenic material may be carried by particles of any size. The MSA
(Mine Safety Appliances Company) type FWS-D polyvinyl chloride membrane
filter (P/N 459733, 37 mm diameter) was used for this study owing to
its small pore size (0.5 micron) and weight stability with changing
ambient humidity conditions. These filters ranged in weight from about
12 to 17 mg.
A CAHN 26 electrobalance was used to weigh all samples. While set
at the 50 mg range for all samples, the approximate lower limit of
measurement for the balance was 1 ug. All filters were desiccated at
least 24 hours prior to preweighing and postweighing. Triplicate gra¬
vimetric controls were weighed for all samples. In two cases, when the
sample weight was less than the average of the three corresponding
controls, the resulting weight and concentration is reported as zero.
If one of the three controls appeared to be an out-lying datum, it was
thrown out at the discretion of the investigator.
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All air samples were collected with DuPont constant flow personal
sample pumps (model # P2500) at 2 Lpm for total particulate samples and
1.7 Lpm for respirable samples. All filters were assembled with cellu¬
lose support pads in three-piece polystyrene filter holders
(cassettes). Each respirable sample was collected through a MSA 10 cm
nylon cyclone separator with a particle cut size of 10 um aerodynamic
diameter. Pump calibrations were performed before and after each
sampling period (unless they occurred on the same day) by the bubble
buret method with an in-line filter, and an in-line cyclone for
respirable particulate sampling. The pre- and post-sampling flowrates
were averaged, and the volumes were corrected for temperature and
pressure as follows:
Vc = [spl time(min) X ave flowrate(Lpm)] X
CP/Ps] X [Ts/T]
where
Vc = corrected volume
P = barometric pressure, day of sampling,
mmHg (the Princo U.S. Signal Corps
type barometer readings were corrected
for temperature and latitude)
Ps = Standard pressure, 760 mmHg
Ts = Standard temperature, 298 °K
T = ambient temperature (usually 295 "K)
After postweighing, each filter (excluding most controls) were put
in 50 ml centrifuge tubes, sealed with teflon tape, labeled, and stored
at less than 0 °C. These samples would be analyzed by RAST inhibition
assay at a later date. In order to limit the scope of this study all
samples were to be RAST tested for two specific rat-derived antigens
only: urinary protein and dander. Therefore, all air samples were
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collected during work with rats. Rats used in this facility were
almost exclusively "CD" or "F-344" rats.
Two "blanks", unweighed filters, were put directly into tubes and
sealed. Three to five controls from various areas, which exhibited the
typical slight weight change, were also sealed and frozen to examine
the effects of contamination during weighing or diffusion contamination
(the cassette plugs were removed during sampling time for most
controls). Other controls were as follows: an outside air sample
taken from the roof of the facility; an industrial hygiene laboratory
air sample, where animals are never used, two floors above the animal
areas and on a separate ventilation supply; and a mouse room air
sample, to test for holding room cross contamination, as different spe¬
cies are usually housed in different rooms.
Sampling Strategy
Three basic types of samples were collected. Area samples were
collected to gather information on ambient concentrations of con¬
taminants in various areas, which has implications for casual, or
indirect animal exposure, especially to persons in areas where con¬
centration peaks in animal-derived air contamination are expected.
Secondly, 8-hour time-weighted average concentrations were obtained for
the most common and intense exposures, based upon observations and ana¬
lysis of a wide diversity of animal-related work performed by employees
at the NIEHS facility. Time-weighted averages were calculated assuming
zero exposure for the remainder of the time for an 8-hour shift.
Thirdly, specific work "tasks" were sampled. A task is a well-defined
undertaking of usually short duration (less than a full 8-hour shift)
•:'..<gijagg;^y-gpfe---"'
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in which a peak exposure to airborne animal-derived allergen con¬
centrations may be expected for a given employee. A task may be
something done routinely several times a day, very infrequently or
completely sporadically and irregularly; it may last only a few minutes
(e.g., guillotine 8 rats) or much longer than a full shift (e.g., a 19
hour neuroendocrinology experiment on live, active canulated rats).
Tasks, like TWA samples, were identified through observations and ana¬
lysis of a wide range of animal-related work performed by the personnel
employed at this facility. Tasks for which particulate exposures were
determined (shown in Table 1) were chosen by considering a multiplicity
of factors, such as intensity of exposure, universality of exposure,
availability/practicality (very rare, brief, or sporadic tasks proved
too difficult to monitor), and nature or type of exposure.
All personal samples, whether "task" or "TWA", were collected in
duplicate, simultaneously collecting total and respirable particulate
on each monitored employee with both filters on the same lapel, the
side of the subject's favored dexterity. This system yielded
"matching" total/respirable samples, eliminating all confounding fac¬
tors of exposure except particle size separation. Therefore,
"respirable percent" of all such samples was reportable. Most task
samples, due to the irregular or infrequent nature of the tasks, were
collected for multiple periods on different people; the filters were
the same and the exposure was cumulative. In such cases, the samples
were returned to freezer storage, along with their corresponding
controls, between periods of collection. An attempt was made to
achieve at least 5 hours of sampling time for all task samples.
Three controls were designated for each personal sample pair and
area sample. Where multiple samples were collected in one area on the
Table 1. Tasks for which particulate exposures were
determined, and a summary of their activities.
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TASK AREA(S) PERFORMED ACTIVITIES INVOLVED
Cage unloading  washroom- clean side
clean corridors






Care/breeding  breeding rooms
surgery suite
Kill, necropsy, user laboratory
tissue work
Live rat exper- user laboratory
imentation
unload clean cages, bottles,
racks, etc.
stack cages, racks
distribute cages, food and
water
clean up, hose down floor
dump and load soiled cages,
etc.
retrieve same from return
corridors
clean up, hose down floor
change bedding, water, feed
clean up, mop









bleeding canulated live rats
Weighing holding room weighing rats on electronic
balance
Lavage surgery suite
Metabolic cage  holding room
experiments
kill rats by injection








same day, only one set of three controls was used. For personal
samples, controls were placed in the room most frequented by the
employee.
Smoking was not allowed in any areas sampled other than the
breakroom, however it was not enforced in the locker rooms or receiving
until the time of the second sample in those areas.
Multiple samples were collected for most area samples and for a
few task and TWA samples.
RESULTS/DISCUSSION
Air Sampling Results
Three logical groups relative to laboratory animal-derived antigen
exposure emerged from the overall picture of air sampling: 1) animal
husbandry-related exposures in animal areas, 2) animal
surgery/manipulation- related exposures usually in adjacent rooms to
the animal holding and breeding rooms, in the same modules and on the
same floor as the animal areas, and 3) user activity centered in the
investigator's own laboratory. (For data summaries, refer to Tables 2,
3, and 4.) Although work with metabolic cages was performed in hus¬
bandry rooms, it was usually performed by highly educated investigators
and involved extensive manipulation of animals and their excrement;
therefore it was grouped in the second category.
The highest particulate exposure by far existed in the clean side
of the washroom. This was due to the aerosolization of autoclaved,
fresh bedding as it was automatically dropped in a continuous curtain
into washed cages passing underneath, and fresh feed which was
dispensed into stainless steel containers from a height of several
feet. The total dust time-weighted average for this area, 0.97 mg/M^,
was very near the threshold limit value of 1 mg/M^ for hardwoods. The
variability of some sample results in certain areas reflect the range
of day to day activity, such as in the return side of the wash
room. Other factors affecting the results included the number of
animals, their activity level, the presence or absence of filter bonnets
36
Table 2. Particulate Concentrations of Area Samples








1 washroom- clean side
























i   78 56 2 117 , 38
70 41 2 99, 41
35 29 3 59, 42, 3
18 5 2 21, 14
14 13 2 23, 4
11 16 2 22, 0
10 1 2 11, 9
8 7 3 12, 11, 0
21 24 6
55 1 55
31 16 2 42, 19
12 16 2 23, 0
28 21 5
26 20 4 53, 29, 16, 6
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Table 3. Particulate Exposure Among Laboratory
Animal Workers: TASK Samples
TASK
CONCENTRATION No. of INDIVIDUAL
(ug/M^)        % No. of Splg   CONCENTRATIONSTotal (Respirable) Respirable Samples Periods (ug/M^)
Cage unloading 3038 (174) 6    1(]L)  5(5)
Cage loading 276 (27) 10    1(]L)  6(6)
Animal care 272+83''(62) 23    2(]L)  3,4(3) 331,213(62)
Care/breeding 181 (21) 12    1(]L)  4(4)
Kill, necropsy,
tissue work
149 (74) 50    1(]L)  1(1)
Surgical
implants
105 (44) 42    1(]0  2(2)
Weighing rats 78 (4) 5    1(]L)  2(2)
Live rat exper¬
imentation
29 (29) 100    1(]L)  1(1)
Lavage 29 (23) 79    1(]L)  3(3)
Metabolic cage
work
27 (2) 7    1(]L)  4(4)
Mean + StOev
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over the cages, smoking in the area, and employee work practices. All
five TWAs measured were lower than their corresponding task samples, as
expected. The respirable percent of the samples ranged from 5 to 100%;
there was no clear pattern in these values.
Control of Antigen Exposure
Effective controls of human exposure to animal allergens in the
husbandry areas are commonly employed already; they exist for the pur¬
pose of animal and human health protection. These controls include
filter caps for individual cages, the wearing of surgical masks by
employees, a reasonable room air exchange rate, frequent bedding
change, and personal protective equipment such as gloves, coveralls,
hair covers, and shoe covers. Tighter filter caps for aerosol reduc¬
tion would amplify two of their inherent disadvantages, namely, reduced
gaseous exchange and extra labor (22). Increasing the ventilation
exchange rate would be uneconomical and upset an already delicate air
pressure balance system used in many facilities. Administrative
controls, such as worker rotation or transfer, is to a large degree the
problem precipitating this study, and consequently can in no way be
considered a proper control.
One important control method which is often overlooked may be
employee work practices. Rats belong to a group of animal species
which cause a high emission of particles and microorganisms (47). It
is evident that the concentration of aerosol depends partly on animal
density and activity patterns (44,47). When filter top cages are not
used the floor in the rooms with rats will be covered with a dense
layer of particles in the morning, due to their high level of nocturnal
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activity. This is the time of lowest airborne concentrations. Where
filter tops are not in use, the floor should be washed first before
working in the room rather than washing the floor after working in the
room, to avoid stirring up the dust. Cleaning and other work in the
rodent rooms should be done in the early morning when the reduced aero¬
sol concentrations constitute less threat to employee health. Any
disturbance of animals will result in renewed aerosol emissions
released to the room. If the worker is aware of this fact he will to
some extent be able to control the emission by his quiet work and beha¬
vior towards the animals. This can apply to laboratory investigators
as well.
The surgical masks which are routinely used in animal facilities
are meant for animal protection rather than human protection, and can¬
not be considered a protective device as they are not approved for
exposure even to dust and mist. Despite this fact, numerous allergy
sufferers were observed using these masks for protection. Only twice
were respirators approved for dust observed to be used, but even then
they were worn in such a way as to void the approval. Allergy suf¬
ferers should as a last resort have respirators approved for dust,
perhaps with high-efficiency filters, made available to them and should
be trained in their limitations and proper use. Immunotherapy has also
been an effective means of relief in some cases where source control is
not feasible.
No conventional laminar flow or funnel systems attached to cages,
filter racks, or ventilated cage racks successfully protect husbandry,
housekeeping, or other animal workers from animal-derived aeroallergens
as many animal manipulations must be done outside of the containment.
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Only devices or systems which provide some form of physical or air
barrier separating animals from personnel can constitute a viable engi¬
neering control. Unfortunately, this does not presently appear to be
economically feasible when large numbers of animals are concerned.
Also, ventilation is required for manipulation operations such as cage
cleaning, sacrifice, and necropsy.
RECOMMENDATIONS FOR FUTURE STUDIES
RAST test results (in ng/M3 of specific antigen) for samples
collected during this study may vary widely and may not correspond
closely with particulate results. The following system for assigning
exposure levels for rat-exposed workers for this and other similar
cohort studies is suggested.
Every task, TWA, and area sample will have an average concentra¬
tion for each specific antigen tested (urine and pelt, in this case).
The highest assay result of each specific antigen can be assigned a
"severity index" of 1, a "full dose", and the others assigned propor¬
tionally. Each sample could then be described by a severity index for
each specific allergen assay. For example, if four samples were taken,









900 ng/M3 / 0.75
70 ng/M3 / 0.06
300 ng/M3 / 0.25
1200 ng/M3 / 1.00
2700 ng/M3 / 1.00
270 ng/M3 / 0.10
490 ng/M3 / 0.18
540 ng/M3 / 0.20
As the prospective cohort study proceeds, the epidemiologist will
want to periodically calculate the cumulative doses of the exposed
group. The data from the questionnaire must elucidate certain infor¬
mation from the participants: what particular tasks with animals are
performed, how many hours per day/week each task is performed, and the
'yX'^JBg*"-"'^'^ <"^-'"-" ;^^
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symptomatology at the given point in time. For each antigen assayed
and for each participant, the severity indices of the tasks they are
involved in may be multiplied by their corresponding duration of expo¬
sure and then totaled. To derive a person's dose after, say, three
years, their total severity-hours may be divided by the number of work
hours in a year. The highest possible exposure then would be "3",
meaning a 1,200 ng/M^ exposure (for rat dander, in our example) full
time for 3 years, or 3 severity-years. A lower index, such as 2.0
would indicate a 67% of maximum possible exposure averaged over three
years (800 ng/M^ for 3 years, full-time), or a real dose equivalent to
2 full years at 1,200 ng/M^. A severity-year system can be easily
translated back to real dose by multiplying the index by the "full
dose" concentration. Then a table or graph may be set up showing the
progress of disease in the sample populations by increments of time
(Figure 5A), or by accumulated dose (Figure 5B).
Some confounding factors may be easily corrected for. Suppose
that the severity index for an 8-hour TWA for holding room work is
0.50. It is known that in developing the 0.50 index, certain factors
were true: 200 to 250 rats occupied the room on the average, the air
exchange rate was 15 changes per hour, the room dimensions were about
10 feet by 20 feet, etc. If the individual whose exposure is being
investigated worked in a room with 50% more rats, or where the ven¬
tilation was substandard, or in a crowded and small room, etc., the
0.50 index may be adjusted accordingly. Exactly how much to adjust is
unknown and deserves further study. Also, tasks performed for which
there is no severity index may be assigned the same or a similar index
to one with similar factors surrounding the exposure, and for which an
index is determined.
100%-
FIGURE 5A Change In Percent of Studied Populations
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Cumulative dose  (severity-years, or  "full  dose years")
for exposed, and zero dose time for controls
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Many other confounding factors, such as age, sex, atopy, pre¬
existing pulmonary disease, smoking, socio-economic strata, etc., may
be adjusted for by matching controls or by appropriately stratified
analysis. Other important confounding factors may be controlled by
selecting a control group of individuals who do similar work in the
same facility, but not animal related. This may control for chemical
exposures and employee questionnaire bias, and other more subtle fac¬
tors.
Other interferences must be controlled clinically. Participants
who are strongly allergic to non-animal derived allergens found in the
atmosphere of their work area might be excluded from the study, since
this could mask a progressive allergic reaction to rats. Participants
should be tested by skin prick for some common allergens, such as house
dust and ragweed as well as other allergens potentially found in
laboratory animal-related work environments, such as birch, maple, and
beech, the hardwood constituents of bedding at this facility.
To better evaluate the potential for physiological impairment of
aerosols generated in laboratory animal work, several of the air
samples should be examined by RAST test for house dust, ragweed
allergen, the bedding hardwoods, and bacterial endotoxins. Endotoxins
are pyrogenic lipopolysaccharide-protein complexes contained in cell
walls of gram-negative bacteria, including non-infectious gram-negative
bacteria, which are released only on bacterial lysis. Endotoxins have
been shown to be airborne in significant concentrations among some
poultry workers (9,23).
After accumulated doses are calculated and level of symptomatology
of allergy or asthma is known from questionnaires and clinical find¬
ings, the incidence or progression of the disease may be evaluated.
CONCLUSIONS
Total and respirable particulate concentrations have now been
determined for most common laboratory animal worker exposures using
standard industrial hygiene air sampling techniques. These results
show that the clean side of the cage and rack washing operation have by
far the highest concentrations, due to the generation of dust from
falling animal feed and bedding. Wide variability of results is seen
in some areas. This may be explained by several factors, such as humi¬
dity, smoking in the area, volume of animals in the area and their
activity, the degree of worker-animal contact and manipulation, and
employee work practices. Improved employee work practices and proper
personal protective equipment may be the most pragmatic means of
allergy and asthma protection. The RAST test results of the air
samples should prove invaluable for following the incidence and
progression of laboratory animal allergy and asthma, and determining
the relationship of dose to symptoms.
Further air sampling is required to narrow the confidence limits
of concentrations corresponding to specific tasks and other samples,
and to find particulate concentrations associated with animal species
other than the rat.
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